Development of Lipomer Nanoparticles for the Enhancement of Drug Release, Anti-Microbial Activity and Bioavailability of Delafloxacin

Delafloxacin (DFL) is a novel potent and broad-spectrum fluoroquinolone group of antibiotics effective against both Gram-positive and negative aerobic and anaerobic bacteria. In this study, DFL-loaded stearic acid (lipid) chitosan (polymer) hybrid nanoparticles (L-P-NPs) have been developed by singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwer, Md. Khalid, Iqbal, Muzaffar, Muharram, Magdy M., Mohammad, Muqtader, Ezzeldin, Essam, Aldawsari, Mohammed F., Alalaiwe, Ahmed, Imam, Faisal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151119/
https://www.ncbi.nlm.nih.gov/pubmed/32168906
http://dx.doi.org/10.3390/pharmaceutics12030252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151119/
https://www.ncbi.nlm.nih.gov/pubmed/32168906
http://dx.doi.org/10.3390/pharmaceutics12030252

Ejemplares similares